THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Stock
Total 13F shares
1,371,546
Share change
-7,891
Total reported value
$653,000
Price per share
$0.48
Number of holders
11
Value change
-$7,622
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q3 2020

As of 30 Sep 2020, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,371,546 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, Fisher Asset Management, LLC, BLAIR WILLIAM & CO/IL, BlackRock Inc., NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and Geneos Wealth Management Inc.. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.